WINTHROP'S FIRST MULTIPLE MYELOMA PATIENT ACHIEVES COMPLETE REMISSION THROUGH STEM CELL AUTOLOGOUS TRANSPLANTATION THERAPY


Vol. 8 No. 2
October 1998

  • Winthrop Dedicates The New Life Center for Labor/Delivery/Recovery

  • Multiple Sclerosis Treatment Program Opens at Winthrop

  • Elected Officials Congratulate Winthrop-University Hospital on Receiving New York's Largest Individual Hospital Award from the New York State Health Workforce Retraining Initiative

  • Winthrop is Designated a Community Training Center for Life Support

  • Winthrop-University Hospital's Stroke Team....A Team Approach to Saving Lives

  • Winthrop Opens New Breast HealthCare Program Educational Health Forums Are Planned for October

  • Winthrop's Center for Crohn's Disease and Colitis Helps Patients Achieve Relief and Remission

  • Winthrop's Pulmonary Rehabilitation Program and Lung Center Participate in a Prestigious International Trial

  • Winthrop Home Health Care Gives People the Option of Living at Home - Rather than in a Long Term Care or Skilled Nursing Facility

  • Winthrop Dedicates The New Life Center

  • Dr. Douglas Katz Is a Co-Developer of CTVPA: A Modification of Spiral CT Scanning of the Chest for Suspected Blood Clots

  • A Third Cardiac Catheterization Laboratory Opens at Winthrop

  • Pediatric Cardiology at Winthrop

  • Women's Cardiology Program at Winthrop-University Hospital Takes Three-Pronged Approach

  • Winthrop's First Multiple Myeloma Patient Acheives Complete Remission through Stem Cell Autologous Transplantation Therapy

  • Perspectives In Health

    Back to Publications

  • A he first multiple myeloma patient to undergo Stem Cell Autologous Transplantation Therapy at Winthrop is a success story: he has achieved complete remission.

    "The disease is followed by measuring the level of abnormal protein in the blood," explains Jeffrey G. Schneider, MD, Faculty Attending Oncologist-Hematologist with Winthrop's Division of Oncology-Hematology. "We are happy to report its total disappearance from the patient's blood."


    "While stem cell autologous therapy is not a cure, the procedure can provide a lengthy remission, compared with the results of conventional chemotherapy."
    Harry Staszewski, MD, Chief, Oncology-Hematology Division

    The patient - Henry W. Schmitt, a 55-year-old accountant - underwent two consecutive outpatient stem cell transplantations at Winthrop's Oncology-Hematology Division Suite, 222 Station Plaza North, Mineola. The New York Blood Center supported Winthrop with technological assistance and personnel.

    "The unique aspect of this program is the degree to which treatment has been shifted both to the outpatient setting and home," comments Dr. Schneider, who directed, administered, and monitored Mr. Schmitt's therapy.

    A Bad Shock - with a Happy Ending
    At the onset of his experience, Mr. Schmitt was unaware that he was seriously ill. Troubled by unexplained fatigue, and suspecting that he had contracted Lyme Disease through an insect bite, he visited his primary care physician, Alan Lipp, MD, of Winthrop's Voluntary Medical Staff. Not long afterwards, Mr. Schmitt received an evening telephone call from Dr. Lipp, who soberly informed him that he was, of necessity, referring him to Dr. Jeffrey Schneider for further tests and treatment. There was no room for equivocation.

    "I simply could not comprehend what Dr. Lipp was talking about," admits Mr. Schmitt. "I was shocked. My wife, Mary, was equally shocked. I made an appointment with Dr. Schneider, who rendered the diagnosis of multiple myeloma. I knew only that it was some kind of a blood disorder. No one in my family had ever had multiple myeloma. I could not identify any causative factor."

    Through informed discussions with Dr. Schneider, bolstered with his own personal research on the Internet, Mr. Schmitt learned that multiple myeloma is treatable. "After Dr. Schneider outlined the plan of treatment, I felt hopeful. I had, and continue to have, the fullest confidence in my physicians and in Winthrop's program."

    Beginning with three 28-day courses of standard outpatient chemotherapy, Mr. Schmitt spent the first three months receiving two chemotherapy drugs, to which he responded satisfactorily. "The first three treatments enabled us to get the disease under control, so that we could go on to the stem cell transplantation," explains Dr. Schneider. At that point, Mr. Schmitt was able to return to work.

    Within a few weeks, Mr. Schmitt supported the next step of his therapy by self-injecting growth factors at home - to aid in the stimulation of stem cells in the blood stream, which would be harvested through a collection procedure known as leukapheresis.

    Once his stem cells were collected and frozen, he returned home to rest and recover, prior to beginning "megadose" chemotherapy - 20 times the standard dose - as an outpatient.

    As a second stem cell transplant is the recommended protocol, Mr. Schmitt underwent the procedure a second time, about six weeks later.

    Stem cell autologous therapy, followed with megadose chemotherapy, is far from easy, even when the patient is as courageous and determined as Mr. Schmitt. After each treatment, he suffered weakness, dehydration, and mucositis, which occasioned admission to Winthrop's dedicated oncology unit - for observation, infection control, and comfort measures. Nonetheless, he knew the side effects, though enormously unpleasant, were only temporary - which helped him to tolerate the difficult aftermath of both treatments.

    Today, Mr. Schmitt is enjoying a complete remission, and will be followed the rest of his life through blood and bone marrow tests.

    "My husband is the bravest person I have ever met," Mary Schmitt declares. The couple has urged Winthrop to tell their story to the public. "Everyone should know about stem cell autologous transplantation therapy at Winthrop, in case they know someone who could be helped," the Schmitts add.

    For further information, contact Winthrop's Oncology-Hematology Division at 516-663-2310.



    [ Home | Search | Contact | Directions | Privacy Notice ]

    Winthrop-University Hospital | 259 First Street | Mineola NY 11501 | 516-663-0333

    This site provides information as a resource. It is not a substitute for professional medical advice.
    Always consult a physician or healthcare provider for treatment and guidance toward good health.
    Copyright © 2008 Winthrop-University Hospital. All rights reserved. Long Island Web Design